A biobank for cardiovascular research at UAB
UAB Cardiovascular Research Biobank
This study is collecting blood and DNA samples from people to see how genetics relate to heart disease, diabetes, and obesity, with the goal of finding better ways to prevent and treat these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Trial ID | NCT05067231 on ClinicalTrials.gov |
What this trial studies
The UAB Cardiovascular Research Biobank (CARBON) aims to collect and store biological materials, such as DNA and blood samples, along with health and personal information from a large population over time. This resource will enable researchers to investigate the relationships between genetic factors and various cardiovascular diseases, hypertension, diabetes, and obesity. By analyzing the data, researchers hope to identify risk factors and develop new strategies for prevention and treatment of these conditions. The biobank will also facilitate studies on how genetic differences affect individual responses to treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are interested in contributing to cardiovascular research.
Not a fit: Patients under 18, pregnant women, and those associated with the Division of Cardiovascular Disease at UAB may not benefit from this study.
Why it matters
Potential benefit: If successful, this biobank could lead to improved detection, treatment, and prevention strategies for cardiovascular diseases and related conditions.
How similar studies have performed: Other biobanks have shown success in advancing research in cardiovascular diseases and related conditions, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age more than or equal to 18 Exclusion Criteria: * Age \<18, at screening * Employees or students associated with the Division of Cardiovascular Disease at UAB will not be recruited due to their vulnerable status and susceptibility to coercion. * Women who are pregnant or who can become pregnant and not practicing an acceptable method of birth control.
Where this trial is running
Birmingham, Alabama
- University of Alabama at Birmingham — Birmingham, Alabama, United States (Recruiting)
Study contacts
- Principal investigator: Pankaj Arora, MD, FAHA — University of Alabama at Birmingham
- Study coordinator: Nehal Vekariya, MS
- Email: nvekariya@uabmc.edu
- Phone: 205-934-7173
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.